Latest News
Breaking news and real-time updates from the ASX small-cap market
CBA Up 8%: Double Down on NAB or Add Small Caps PPM, JDO?
CBA jumps 8% to above $171, reigniting the Big Four debate as rivals rally; strong profit, higher dividend, and rich multiples raise the risk-reward for banks.
Meteoric Resources Delivers Outstanding Mixed Rare Earth Recoveries from Caldeira Pilot Plant
Meteoric Resources hits 70% magnet rare earth recovery at Caldeira pilot (Nd 70%, Pr 71%, Dy 56%, Tb 61%), de-risks commercial MREC plant ahead of DFS.
Tivan Delivers Ultra High-Grade Fluorite in Maiden Sandover Drilling, Eyes Acidspar Production
Tivan (ASX: TVN) has reported significant high-grade fluorite results from its maiden Sandover drilling campaign.
Paradigm Biopharmaceuticals Publishes Canine Osteoarthritis Study Showing Durable PPS Benefits
Paradigm Biopharmaceuticals (ASX: PAR) reports durable 26-week canine OA PPS benefits in peer-reviewed PLOS One, bolstering translational human OA potential.
Greenvale Energy Enhances Regional Discovery Potential of Oasis Uranium Project
GRV leaps as Sentinel-2 reveals nine regional targets at Oasis uranium project, boosting regional discovery potential ahead of 2026 exploration.
Mithril Confirms High-Grade Silver-Gold Mineralisation in Maiden Drilling at Copalquin’s Target 5
Mithril confirms high-grade silver-gold at Copalquin Target 5 in maiden drilling; standout 2.75m at 660 g/t AgEq and 0.6m at 38.3 g/t Au, 4,520 g/t Ag.
Great Dirt Resources Raises $1.446 Million in Placement to Fund Growth and New Opportunities
Great Dirt Resources (GR8.ASX) has secured firm commitments for a $1.45 million placement to fund ongoing projects and new opportunities.
EcoGraf Secures Technical Assistance from EIB to Develop TanzGraphite Business and HFfree Technology
EcoGraf (ASX: EGR) secures EU-backed EIB technical aid to push TanzGraphite, HFfree purification, and Epanko expansion into Europe's battery supply chain.
TruScreen Validated as Superior Cervical Cancer Screening Tool in Major Chinese Study
TruScreen Group (ASX: TRU) announced strong validation results from a major Chinese study for its cervical cancer screening tool, positioning it for guidelin
Rhythm Biosciences begins ColoSTAT commercial deployment with first physician enrollment
Rhythm Biosciences (ASX: RHY) has initiated the commercial deployment of its ColoSTAT test by enrolling the first physician in its capped Access Program.
ANSTO Confirms High MREO Recovery at Axel Ree's Caladão, Boosting Dual-Pathway Strategy
Axel REE (ASX: AXL) has announced significant metallurgical test work results from its Caladão project.
G8 Education Flags $350M Goodwill Impairment, Halts Dividend and Buyback Amid Tough Sector Conditions
G8 Education has announced a significant A$350 million non-cash goodwill impairment for FY25, alongside the suspension of its final dividend and share buyback program due to challenging sect